Abstract: A method includes obtaining samples of radio-frequency (RF) uplink data signals received wirelessly at a radio unit of a radio access network, the RF uplink data signals including a first RF uplink data signal received from a user device; providing the samples of the RF uplink data signals as input to at least one machine learning model; in response to providing the samples of the RF uplink data signals as input to the at least one machine learning model, obtaining based on an output of the at least one machine learning model, recovered data of the RF uplink data signals; and sending the recovered data of the RF uplink signals to a destination device.

Abstract: Methods, systems, and apparatus, including computer programs encoded on computer-storage media, for providing one or more values from a distribution of values to a neural network trained to generate simulated channel responses corresponding to one or more radio frequency (RF) communication channels; and obtaining an output of the neural network based on processing the one or more values by the neural network, the output indicating a simulated channel response corresponding to at least one communication channel of the one or more RF communication channels.

Abstract: This application describes methods of treating cystic fibrosis or a CFTR mediated disease comprising administering Compound I or a pharmaceutically acceptable salt thereof. The application also describes pharmaceutical compositions comprising Compound I or a pharmaceutically acceptable salt thereof and optionally comprising one or more additional CFTR modulating agents.

Abstract: Systems and methods for removal of gas phase contaminants may utilize catalytic oxidation. For example, a method may include passing a gas that includes a gas phase contaminant through a catalytic membrane reactor at a temperature of about 150° C. to about 300° C., wherein the catalytic membrane reactor includes a bundle of tubular inorganic membranes, wherein each of the tubular inorganic membranes comprise a macroporous tubular substrate with an oxidative catalyst and a microporous layer disposed on a bore side of the macroporous tubular substrate, and wherein at least about 50% of the gas flows through the tubular inorganic membranes in a Knudsen flow regime; and oxidizing at least some of the gas phase contaminant with the oxidative catalyst layer, thereby reducing a concentration of the gas phase contaminant in the gas.

Abstract: Compounds of the present invention and pharmaceutically acceptable compositions thereof, are useful as modulators of ATP-Binding Cassette (“ABC”) transporters or fragments thereof, including Cystic Fibrosis Transmembrane Conductance Regulator (“CFTR”). The present invention also relates to methods of treating ABC transporter mediated diseases using compounds of the present invention.

Abstract: Management of rights and royalties associated with a media. Embodiments herein disclose a method and system for managing rights associated with a media among at least one contributor to the media Embodiments herein disclose a method and system for managing rights associated with a media by an entity that controls the rights to the media Embodiments herein disclose a method and system for managing royalty for a media, based on the contributors and their designated share of the royalty.

Abstract: Systems and methods for removal of gas phase contaminants may utilize catalytic oxidation. For example, a method may include passing a gas that includes a gas phase contaminant through a catalytic membrane reactor at a temperature of about 150° C. to about 300° C., wherein the catalytic membrane reactor includes a bundle of tubular inorganic membranes, wherein each of the tubular inorganic membranes comprise a macroporous tubular substrate with an oxidative catalyst and a microporous layer disposed on a bore side of the macroporous tubular substrate, and wherein at least about 50% of the gas flows through the tubular inorganic membranes in a Knudsen flow regime; and oxidizing at least some of the gas phase contaminant with the oxidative catalyst layer, thereby reducing a concentration of the gas phase contaminant in the gas.